Abstract
The epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase that plays an important role in tumor growth, invasion and metastasis. EGFR Positive immunoreactivity ranged from focal to diffuse in overexpression has been shown in many different tumors and multiple EGFR-targeted therapies are currently being investigated. Renal epithelioid angiomyolipoma (epiAML) is an aggressive and potentially malignant variant of conventional angiomyolipoma (cAML). Currently, the status of EGFR expression in epiAML is unknown. We compared EGFR protein expression, as well as expression levels of several other tumor regulatory proteins including c-Kit, p53, alpha-catenin, beta-catenin and osteopontin in 6 cases of cAML and 10 cases of epiAML by semiquantitative immunohistochemistry (IHC). EGFR gene amplification was analyzed by fluorescent in situ hybridization (FISH). Within epiAML, EGFR immunostaining was significantly higher when compared to cAML (90% vs. 16.7%, p<0.01). epiAML, whereas no diffuse reactivity was found in cAML. EGFR gene amplification was not identified in either cAML or epiAML as illustrated by FISH. Expression levels of c-Kit, osteopontin, p53, alpha-catenin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
